Osteoprotegerin, RANKL, ADMA, and Fetuin-A serum levels in children with type I diabetes mellitus

Decreased levels of homoarginine and asymmetric dimethylarginine in children with type 1 diabetes: associations with cardiovascular risk factors but no effect by atorvastin

(2015) Andreas Krebs et al.   JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM

Osteoprotegerin, Soluble Receptor Activator of Nuclear Factor-κB Ligand, and Subclinical Atherosclerosis in Children and Adolescents with Type 1 Diabetes Mellitus

(2013) Irene Lambrinoudaki et al.   International Journal of Endocrinology

Role of fetuin-A in atherosclerosis associated with diabetic patients

(2012) Monika Singh et al.   JOURNAL OF PHARMACY AND PHARMACOLOGY

Adipokines, bone-derived factors and bone turnover in obese children; evidence for altered fat-bone signalling resulting in reduced bone mass

(2010) P. Dimitri et al.   BONE

Review article: Asymmetric dimethylarginine as a mediator of vascular dysfunction and a marker of cardiovascular disease and mortality: an intriguing interaction with diabetes mellitus

(2010) Maike Anderssohn et al.   Diabetes & Vascular Disease Research

Fetuin-A Levels Are Increased in Patients With Type 2 Diabetes and Peripheral Arterial Disease

(2010) D. P. Lorant et al.   DIABETES CARE

Early Signs of Atherosclerosis in Diabetic Children on Intensive Insulin Treatment: A population-based study

(2010) H. D. Margeirsdottir et al.   DIABETES CARE

Low Levels of Asymmetric Dimethylarginine in Children with Diabetes Mellitus Type I Compared with Healthy Children

(2010) Martina Huemer et al.   JOURNAL OF PEDIATRICS

Osteoprotegerin as a Predictor of Coronary Artery Disease and Cardiovascular Mortality and Morbidity

(2010) Shreenidhi M. Venuraju et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Does osteoprotegerin relate to micro- and macrovascular complications in long-term type 1 diabetes?

(2010) Jakob Grauslund et al.   SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION

Low serum osteoprotegerin levels in normoalbuminuric type 1 diabetes mellitus

(2009) Dhruv K. Singh et al.   ACTA DIABETOLOGICA

Osteoprotegerin and Soluble Receptor Activator of Nuclear Factor-κB Ligand and Risk for Coronary Events

(2009) Anne G. Semb et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

A study of endothelial function and circulating asymmetric dimethylarginine levels in people with Type 1 diabetes without macrovascular disease or microalbuminuria

(2009) Latika Sibal et al.   Cardiovascular Diabetology

Role of asymmetric-dimethyl-l-arginine (ADMA) and nitrite/nitrate (NOx) in the pathogenesis of oxidative stress in female subjects with uncomplicated type 1 diabetes mellitus

(2009) Dario Pitocco et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Markers of bone destruction and formation and periodontitis in type 1 diabetes mellitus

(2009) David F. Lappin et al.   JOURNAL OF CLINICAL PERIODONTOLOGY

The Physiologic Development of Fetuin-A Serum Concentrations in Children

(2009) Martin Häusler et al.   PEDIATRIC RESEARCH

Asymmetric Dimethylarginine Independently Predicts Fatal and Nonfatal Myocardial Infarction and Stroke in Women

(2008) Tora Leong et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Osteoprotegerin, vascular calcification and atherosclerosis

(2008) Ann Van Campenhout et al.   ATHEROSCLEROSIS

Effect of acute variations of insulin and glucose on plasma concentrations of asymmetric dimethylarginine in young people with Type 1 diabetes

(2008) M. Loredana Marcovecchio et al.   CLINICAL SCIENCE

Plasma osteoprotegerin levels predict cardiovascular and all-cause mortality and deterioration of kidney function in type 1 diabetic patients with nephropathy

(2008) A. Jorsal et al.   DIABETOLOGIA

High prevalence of cardiovascular risk factors in children and adolescents with type 1 diabetes: a population-based study

(2008) H. D. Margeirsdottir et al.   DIABETOLOGIA

Elevated plasma adiponectin and decreased plasma homocysteine and asymmetric dimethylarginine in children with type 1 diabetes

(2008) Kaire Heilman et al.   SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION